Abstract
Aim: To study the utility of leaving peritoneal dialysis catheters (PDCs) in situ at the time of deceased donor kidney transplantation (DDKT).
Background: PDCs are commonly not removed at the time of DDKT in case of delayed graft function (DGF). Data to justify this approach is lacking.
Methods: Electronic medical records were retrospectively reviewed for peritoneal dialysis (PD) patients receiving DDKT at a single centre (November 2009 to December 2018). Primary outcomes were the proportion of PDCs accessed post-transplant, and PDC-related infections.
Results: 79 PD patients (median age 57, range 20-73) receiving DDKT were identified. Only 2 (2.5%) had PDCs removed at the time of transplantation. 30 (38%) patients experienced DGF. Of those, 4 (13.3%) underwent PD (median duration 2.5 days, range 1-4) with no PD-related complications; 26 (86.7%) underwent haemodialysis (HD). Of those undergoing HD, 14 (53.8%) required central venous catheter insertion; others had pre-existing arteriovenous fistulae (n = 11) or tunnelled catheter (n = 1). 75/77 (97.4%) patients had PDCs removed at a median time of 79 days (range 4-303). PDCs were not removed in 2 (2.6%) as they resumed chronic PD following graft losses at 88 and 932 days. 4/77 (5.2%) patients with PDCs left in developed exit site infections; 1/77 (1.3%) experienced peritonitis requiring urgent PDC removal. Overall peritonitis rate was 0.05 episodes per patient-year with PDCs in situ.
Conclusions: In this cohort, there was a low rate of PDC use post-DDKT (7.8%), even amongst those with DGF (13.3%). 6.5% of patients developed PDC-related infections. 97.4% of patients required a second operation (PDC removal). The risks of leaving PDCs in situ at the time of DDKT may outweigh the benefits for the majority of patients.
Background: PDCs are commonly not removed at the time of DDKT in case of delayed graft function (DGF). Data to justify this approach is lacking.
Methods: Electronic medical records were retrospectively reviewed for peritoneal dialysis (PD) patients receiving DDKT at a single centre (November 2009 to December 2018). Primary outcomes were the proportion of PDCs accessed post-transplant, and PDC-related infections.
Results: 79 PD patients (median age 57, range 20-73) receiving DDKT were identified. Only 2 (2.5%) had PDCs removed at the time of transplantation. 30 (38%) patients experienced DGF. Of those, 4 (13.3%) underwent PD (median duration 2.5 days, range 1-4) with no PD-related complications; 26 (86.7%) underwent haemodialysis (HD). Of those undergoing HD, 14 (53.8%) required central venous catheter insertion; others had pre-existing arteriovenous fistulae (n = 11) or tunnelled catheter (n = 1). 75/77 (97.4%) patients had PDCs removed at a median time of 79 days (range 4-303). PDCs were not removed in 2 (2.6%) as they resumed chronic PD following graft losses at 88 and 932 days. 4/77 (5.2%) patients with PDCs left in developed exit site infections; 1/77 (1.3%) experienced peritonitis requiring urgent PDC removal. Overall peritonitis rate was 0.05 episodes per patient-year with PDCs in situ.
Conclusions: In this cohort, there was a low rate of PDC use post-DDKT (7.8%), even amongst those with DGF (13.3%). 6.5% of patients developed PDC-related infections. 97.4% of patients required a second operation (PDC removal). The risks of leaving PDCs in situ at the time of DDKT may outweigh the benefits for the majority of patients.
| Original language | English |
|---|---|
| Pages (from-to) | 57 |
| Number of pages | 1 |
| Journal | Nephrology |
| Volume | 26 |
| Issue number | S2 |
| Publication status | Published - 26 Aug 2021 |
| Externally published | Yes |
| Event | Annual Scientific Meeting of the Australian-and-New-Zealand-Society-of-Nephrology 2021 - virtual/online Duration: 28 Aug 2021 → 1 Sept 2021 Conference number: 56th https://onlinelibrary.wiley.com/toc/14401797/2021/26/S2 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver